Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin

Journal of Inflammation

Volumn 3, Issue , 2006, Pages

  Djanani, Angela ^a   Mosheimer, Birgit ^a   Kaneider, Nicole C ^a   Ross, Christopher R ^b   Ricevuti, Giovanni ^c   Patsch, Josef R ^a   Wiedermann, Christian J ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b KANSAS STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; LEUCINE; METHIONINE; PHENYLALANINE; PR 39; PROTEOHEPARAN SULFATE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL SURFACE; CHEMOTAXIS;

MAMMALIA; SUIDAE;

EID: 33750919254     PISSN: 14769255     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-3-14     Document Type: Article

References (42)

1. Lehrer RI, Ganz T: Defensins of vertebrate animals. Curr Opin Immunol 2002, 14:96-102.
2. Lehrer RI, Ganz T: Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol 2002, 9:18-22.
3. Zaiou M, Gallo RL: Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med 2002, 80:549-61.
4. Zanetti M, Gennaro R, Romeo D: Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995, 374:1-5.
5. Zanetti M, Del Sal G, Storici P, Schneider C, Romeo D: The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics. J Biol Chem 1993, 268:522-6.
6. Bagella L, Scocchi M, Zanetti M: cDNA sequences of three sheep myeloid cathelicidins. FEBS Lett 1995, 376:225-8.
7. Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R: Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 1977, 272:13088-93.
8. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH: FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995, 92:195-9.
9. Storici P, Scocchi M, Tossi A, Gennaro R, Zanetti M: Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. FEBS Lett 1994, 337:303-7.
10. Tossi A, Scocchi M, Zanetti M, Storici P, Gennaro R: PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity. Eur J Biochem 1995, 228:941-6.
11. Zanetti M, Litteri L, Gennaro R, Horstmann H, Romeo D: Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules. J Cell Biol 1990, 111:1363-71.
12. Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrun M, Bernfield M: Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 1994, 91:11035-9.
13. Frohm NM, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999, 67:2561-6.
14. Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N: The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 1997, 90:2796-803.
15. Agerberth B, Lee JY, Bergman T, Carlquist M, Boman HG, Mutt V, Jornvall H: Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 1991, 202:849-54.
16. Shi J, Ross CR, Chengappa MM, Blecha F: Identification of a proline-arginine-rich antibacterial peptide from neutrophils that is analogous to PR-39, an antibacterial peptide from the small intestine. J Leukoc Biol 1994, 56:807-11.
17. Shi J, Ross CR, Chengappa MM, Sylte MJ, McVey DS, Blecha F: Antibacterial activity of a synthetic peptide (PR-26) derived from PR-39, a proline-arginine-rich neutrophil antimicrobial peptide. Antimicrob Agents Chemother 1996, 40:115-21.
18. Boman HG, Agerberth B, Boman A: Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 1993, 61:2978-84.
19. Ohtake T, Fujimoto Y, Ikuta K, Saito H, Ohhira M, Ono M, Kohgo Y: Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells. Br J Cancer 1999, 8:393-403.
20. Li J, Post M, Volk R, Gao Y, Li M, Metais C, Sato K, Tsai J, Aird W, Rosenberg RD, Hampton TG, Sellke F, Carmeliet P, Simons M: PR39, a peptide regulator of angiogenesis. Nat Med 2000, 6:49-55.
21. Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A: Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 1998, 101:877-89.
22. Parmley RT, Hurst RE, Takagi M, Spicer SS, Austin RL: Glycosaminoglycans in human neutrophils and leukemic myeloblasts: ultrastructural, cytochemical, immunologic, and biochemical characterization. Blood 1983, 61:257-66.
23. Yeaman C, Rapraeger AC: Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form. J Cell Physiol 1993, 157:413-25.
24. Yeaman C, Rapraeger AC: Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J Cell Biol 1993, 122:941-50.
25. Huang HJ, Ross CR, Blecha F: Chemoattractant properties of PR-39, a neutrophil antibacterial peptide. J Leukoc Biol 1997, 61:624-9.
26. Dunzendorfer S, Kaneider N, Rabensteiner A, Meierhofer C, Reinisch C, Romisch J, Wiedermann CJ: Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 2001, 97:1079-85.
27. Mertens G, Cassiman JJ, Van den Berghe H, Vermylen J, David G: Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem 1992, 267:20435-43.
28. James PE, Madhani M, Ross C, Klei L, Barchowsky A, Swartz HM: Tissue hypoxia during bacterial sepsis is attenuated by PR-39, an antibacterial peptide. Adv Exp Med Biol 2003, 530:645-52.
29. Madhani M, Barchowsky A, Klei L, Ross CR, Jackson SK, Swartz HM, James PE: Antibacterial peptide PR-39 affects local nitric oxide and preserves tissue oxygenation in the liver during septic shock. Biochim Biophys Acta 2002, 1588:232-40.
30. De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O: LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000, 192:1069-74.
31. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, Nagaoka I: A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2000, 106:20-6.
32. Kaneider NC, Egger P, Dunzendorfer S, Wiedermann CJ: Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun 2001, 287:42-6.
33. Cardin AD, Weintraub HJ: Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989, 9:21-32.
34. Andersson E, Rydengard V, Sonesson A, Morgelin M, Bjorck L, Schmidtchen A: Antimicrobial activities of heparin-binding peptides. Eur J Biochem 2004, 271:1219-26.
35. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999, 68:729-77.
36. Wadstrom T, Ljungh A: Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: key events in microbial pathogenicity. J Med Microbiol 1999, 48:223-33.
37. Kjellen L, Lindahl U: Proteoglycans: structures and interactions. Annu Rev Biochem 1991, 60:443-75.
38. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ: Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992, 8:365-93.
39. Chan YR, Gallo RL: PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas). J Biol Chem 1998, 273:28978-85.
40. Honda H, Nakamoto T, Sakai R, Hirai H: p130(Cas), an assembling molecule of actin filaments, promotes cell movement, cell migration, and cell spreading in fibroblasts. Biochem Biophys Res Commun 1999, 262:25-30.
41. Cary LA, Han DC, Polte TR, Hanks SK, Guan JL: Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J Cell Biol 1998, 140:211-21.
42. Wilcox-Adelman SA, Denhez F, Goetinck PF: Syndecan-4 modulates focal adhesion kinase phosphorylation. J Biol Chem 2002, 277:32970-7.